No results for ‘’
Granules India Ltd
₹786.90
(0.61%)
Wed, 24 Jun 2026, 00:48 pm
Health Technology
Pharmaceuticals: Other
24.5KGranules India Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 18.64 | 15.31 | 23 | 8.65 | 6.19 | 8.85 | 5.45 | 6 | 7.01 | 19.26 | 20.57 | 18.52 | 18.91 | 12.32 | 10.92 | 13.82 | 18.45 | 13.83 | 25.71 | 23.55 |
| Price to book ratio | 1.82 | 1.28 | 1.41 | 0.43 | 0.93 | 0.84 | 0.66 | 0.69 | 1.46 | 4.03 | 3.93 | 3.51 | 2.01 | 1.90 | 1.98 | 3.46 | 2.94 | 2.48 | 3.23 | 3.18 |
| Price to sales ratio | 0.80 | 0.63 | 0.93 | 0.26 | 0.41 | 0.39 | 0.25 | 0.26 | 0.49 | 1.36 | 1.86 | 2.16 | 1.49 | 1.28 | 1.41 | 2.34 | 2.02 | 1.58 | 2.31 | 2.64 |
| Price to cash flow ratio | 0 | 26.59 | 0 | 0 | 4.19 | 5.22 | 10.94 | 2.55 | 5.96 | 14.54 | 21.28 | 18.95 | 0 | 12.05 | 8.09 | 18 | 23.80 | 10.35 | 30.69 | 15.41 |
| Enterprise value | 180Cr | 215Cr | 272Cr | 245Cr | 321Cr | 310Cr | 347Cr | 415Cr | 914Cr | 2167Cr | 3041Cr | 3654Cr | 3370Cr | 3815Cr | 4271Cr | 8169Cr | 8312Cr | 7968Cr | 11349Cr | 12671Cr |
| Enterprise value to EBITDA ratio | 9.23 | 8.51 | 9.24 | 0 | 5.17 | 5.65 | 4.57 | 4.78 | 5.72 | 10.30 | 10.96 | 11.89 | 12.02 | 9.90 | 7.52 | 9.38 | 11.18 | 8.54 | 12.77 | 13.17 |
| Debt to equity ratio | 1.29 | 1.36 | 0.80 | 1.05 | 0.72 | 0.62 | 0.88 | 0.99 | 1.21 | 1.12 | 0.97 | 0.73 | 0.75 | 0.65 | 0.48 | 0.39 | 0.43 | 0.40 | 0.41 | 0.39 |
| Return on equity % | 11.46 | 9.68 | 6.15 | 5.06 | 16.10 | 9.90 | 12.89 | 12.54 | 23.89 | 23.12 | 22.52 | 21.02 | 12.01 | 16.69 | 19.89 | 27.36 | 17.34 | 19.06 | 13.38 | 14.45 |
Granules India Ltd Enterprise Value
The Granules India Ltd Enterprise Value is a key financial metric used by investors to evaluate Granules India Ltd's valuation, profitability, and overall financial performance. Tracking the Granules India Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Granules India Ltd (NSE: GRANULES, BSE: 532482) is currently trading at ₹786.90, with a market capitalization of ₹19386.39Cr. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Granules India Ltd Enterprise Value is essential for fundamental analysis.
Granules India Ltd Enterprise Value Current Value
The current Granules India Ltd Enterprise Value stands at 12671Cr.
The latest Granules India Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Granules India Ltd Enterprise Value Historical Trend
The Granules India Ltd Enterprise Value has shown the following historical trend:
- 2024: 12671Cr
- 2023: 11349Cr
- 2022: 7968Cr
- 2021: 8312Cr
- 2020: 8169Cr
The recent rise in Granules India Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Granules India Ltd Enterprise Value Indicates for Investors
The Granules India Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Granules India Ltd.
Granules India Ltd Enterprise Value Analysis Summary
The Granules India Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Granules India Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Granules India Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.